Lange explained on a conference call that one reason for the miss was a flexible treatment protocol that allowed patients to ...
Eli Lilly & Co. said Thursday that its Type 2 diabetes drug Mounjaro and its weight-loss and diabetes drug Zepbound drove a 45% increase in fourth-quarter revenue to $13.53 billion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback